128 related articles for article (PubMed ID: 11908925)
1. New molecular targets and biological therapies in sarcomas.
Scappaticci FA; Marina N
Cancer Treat Rev; 2001 Dec; 27(6):317-26. PubMed ID: 11908925
[TBL] [Abstract][Full Text] [Related]
2. Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches.
Mocellin S; Rossi CR; Brandes A; Nitti D
Cancer Treat Rev; 2006 Feb; 32(1):9-27. PubMed ID: 16338075
[TBL] [Abstract][Full Text] [Related]
3. Novel targets for therapy in paediatric oncology.
Estlin EJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):141-50. PubMed ID: 12476788
[TBL] [Abstract][Full Text] [Related]
4. New approaches in metastatic melanoma: biological and molecular targeted therapies.
Lejeune FJ; Rimoldi D; Speiser D
Expert Rev Anticancer Ther; 2007 May; 7(5):701-13. PubMed ID: 17492933
[TBL] [Abstract][Full Text] [Related]
5. Targeting lethal minimal residual disease in small cell lung cancer.
Patel JD; Krug LM; Azzoli CG; Gomez J; Kris MG; Miller VA
Semin Oncol; 2003 Feb; 30(1):79-85. PubMed ID: 12635092
[TBL] [Abstract][Full Text] [Related]
6. [Targeted therapy of sarcomas].
Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
[TBL] [Abstract][Full Text] [Related]
7. Novel therapies for the treatment of non-small cell lung cancer.
Johnson DH; Schiller JH
Cancer Chemother Biol Response Modif; 2002; 20():763-86. PubMed ID: 12703233
[TBL] [Abstract][Full Text] [Related]
8. Novel targeted therapies in the treatment of soft-tissue sarcomas.
Chao J; Chow WA; Somlo G
Expert Rev Anticancer Ther; 2010 Aug; 10(8):1303-11. PubMed ID: 20735315
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in sarcomas.
Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
[TBL] [Abstract][Full Text] [Related]
10. [Update on soft tissue sarcomas].
Bui BN; Tabrizi R; Dagada C; Trufflandier N; St ckle E; Coindre JM
Bull Cancer; 2002 Jan; 89(1):100-7. PubMed ID: 11847031
[TBL] [Abstract][Full Text] [Related]
11. Advanced NSCLC: from cytotoxic systemic chemotherapy to molecularly targeted therapy.
Hoang T; Schiller JH
Expert Rev Anticancer Ther; 2002 Aug; 2(4):393-401. PubMed ID: 12647982
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
Lorigan P; Eisen T; Hauschild A
Exp Dermatol; 2008 May; 17(5):383-94. PubMed ID: 18312390
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for relapsed small-cell lung cancer.
Azim HA; Ganti AK
Anticancer Drugs; 2007 Mar; 18(3):255-61. PubMed ID: 17264756
[TBL] [Abstract][Full Text] [Related]
14. The role of targeted therapy in non-small cell lung cancer.
Maione P; Rossi A; Airoma G; Ferrara C; Castaldo V; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):29-44. PubMed ID: 15207252
[TBL] [Abstract][Full Text] [Related]
15. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
Riedel RF
Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
[TBL] [Abstract][Full Text] [Related]
16. Soft tissue sarcomas of adults: state of the translational science.
Borden EC; Baker LH; Bell RS; Bramwell V; Demetri GD; Eisenberg BL; Fletcher CD; Fletcher JA; Ladanyi M; Meltzer P; O'Sullivan B; Parkinson DR; Pisters PW; Saxman S; Singer S; Sundaram M; van Oosterom AT; Verweij J; Waalen J; Weiss SW; Brennan MF
Clin Cancer Res; 2003 Jun; 9(6):1941-56. PubMed ID: 12796356
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
Hartmann JT
Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
[TBL] [Abstract][Full Text] [Related]
18. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
Albo D; Farrow B; Berger DH
Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
[TBL] [Abstract][Full Text] [Related]
19. Role of tyrosine kinase inhibitors in cancer therapy.
Arora A; Scholar EM
J Pharmacol Exp Ther; 2005 Dec; 315(3):971-9. PubMed ID: 16002463
[TBL] [Abstract][Full Text] [Related]
20. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Citrin D; Ménard C; Camphausen K
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
